{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T18:24:35Z","timestamp":1781979875850,"version":"3.54.5"},"reference-count":37,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JBM"],"DOI":"10.2147\/jbm.s279736","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T02:53:05Z","timestamp":1620183185000},"page":"245-255","source":"Crossref","is-referenced-by-count":24,"title":["What Does the Economic Burden of Acute Myeloid Leukemia Treatment Look Like for the Next Decade? An Analysis of Key Findings, Challenges and Recommendations"],"prefix":"10.2147","volume":"Volume 12","author":[{"given":"Anna","family":"Forsythe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Sandman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,5]]},"reference":[{"key":"ref1","unstructured":"PDQ Adult Treatment Editorial Board. PDQ Cancer Information Summaries. In: Adult Acute Myeloid Leukemia Treatment (PDQ\u00ae): Health Professional Version. National Cancer Institute (US); 2002."},{"key":"ref2","unstructured":"National Cancer Institute. Acute Myeloid Leukemia - Cancer Stat Facts. SEER; 2013."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"ref4","first-page":"5","author":"Carter","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.6004\/jnccn.2021.0002","volume":"19","author":"Pollyea","year":"2021","journal-title":"J Nat Comprehen Cancer Network"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1182\/hematology.2020000097","volume":"2020","author":"Halpern","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"ref9","unstructured":"Centre for Reviews and Dissemination. Systematic Reviews: CRD\u2019s Guidance for Undertaking Reviews in Health Care; 2009."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"849","DOI":"10.18553\/jmcp.2020.19220","volume":"26","author":"Pandya","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/03007995.2016.1267615","volume":"33","author":"Irish","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40258-013-0032-2","volume":"11","author":"Meyers","year":"2013","journal-title":"Appl Health Econ Health Policy"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1634\/theoncologist.2018-0019","volume":"24","author":"Reyes","year":"2019","journal-title":"Oncologist"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13696998.2019.1678170","author":"Mars\u00e0","year":"2020","journal-title":"J Med Econ"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.leukres.2012.09.018","volume":"37","author":"Leunis","year":"2013","journal-title":"Leuk Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1182\/blood-2019-127957","volume":"134","author":"Hernlund","year":"2019","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.clml.2020.01.011","volume":"20","author":"Patel","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40164-020-00161-7","volume":"9","author":"Yu","year":"2020","journal-title":"Exp Hematol Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1200\/JCO.2017.77.6112","volume":"36","author":"Lancet","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e19013","DOI":"10.1200\/JCO.2018.36.15_suppl.e19013","volume":"36","author":"Kubal","year":"2018","journal-title":"JCO"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1182\/bloodadvances.2019000707","volume":"4","author":"Mabrey","year":"2020","journal-title":"Blood Adv"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1182\/blood-2017-09-801498","volume":"131","author":"Schuurhuis","year":"2018","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/bjh.16355","volume":"188","author":"Loke","year":"2020","journal-title":"Br J Haematol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1182\/blood-2013-02-453175","volume":"122","author":"Ballen","year":"2013","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12185-019-02670-6","volume":"110","author":"Maung","year":"2019","journal-title":"Int J Hematol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1016\/S2352-3026(19)30202-9","volume":"7","author":"Cohen","year":"2020","journal-title":"Lancet Haematol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fonc.2020.00697","author":"Mardiana","year":"2020","journal-title":"Front Oncol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1200\/EDBK_279151","author":"Kansagra","year":"2020","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/jnci\/djy193","volume":"111","author":"Sarkar","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"ref31","volume-title":"Patterns of Undertreatment Among Patients with Acute Myeloid Leukemia (AML) Not Receiving Standard Intensive Induction Chemotherapy","year":"2020"},{"key":"ref32","unstructured":"National Comprehensive Cancer Network, Inc. NCCN\u00ae Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Acute Myeloid Leukemia; 2021."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2012971","volume":"383","author":"DiNardo","year":"2020","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41375-018-0312-9","volume":"33","author":"Cortes","year":"2019","journal-title":"Leukemia"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1200\/JCO.2014.57.0952","volume":"33","author":"Stone","year":"2015","journal-title":"J Clin Oncol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1182\/blood-2019-129876","volume":"134","author":"Foran","year":"2019","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1056\/NEJMoa2004444","volume":"383","author":"Wei","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Journal of Blood Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=69070","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=69070","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T02:53:14Z","timestamp":1620183194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/what-does-the-economic-burden-of-acute-myeloid-leukemia-treatment-look-peer-reviewed-fulltext-article-JBM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":37,"URL":"https:\/\/doi.org\/10.2147\/jbm.s279736","relation":{},"ISSN":["1179-2736"],"issn-type":[{"value":"1179-2736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]}}}